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We have previously described a fluorimetric method to measure ADP-ATP exchange rates in 
mitochondria of permeabilized cells where phosphorylases, kinases, ion pumps exhibiting 
substantial ATP hydrolase activity and other competing reactions interconverting adenine 
nucleotides are present. This was achieved by recording changes in free extramitochondrial 
[Mg2+] reported by the Mg2+-sensitive fluorescent indicator 'Magnesium Green', exploiting the 
differential affinity of ADP and ATP to Mg2+. Cells are permeabilized with digitonin in the 
presence of BeF3- and Na3VO4 inhibiting all ATP-ADP utilizing reactions except for the 
adenine nucleotide translocase-mediated mitochondrial ATP-ADP exchange. The rate of ATP 
appearing in the medium after addition of ADP to energized mitochondria is calculated from 
the measured rate of change in free extramitochondrial [Mg2+] using standard binding 
equations. Here, we have enhanced this method with an improved calibration step, which 
minimizes errors introduced during conversion of the dye-emission signal to free 
extramitochondrial [Mg2+] and further to ATP. Furthermore, we can combine the 
methodologies addressing the kinetics of ADP-ATP exchange to mitochondrial membrane 
potential and to oxygen consumption in the same sample. This may prove to be particularly 
useful for studies of cancer cells which are known to thrive in hypoxic environments, 
harboring mitochondria with respiratory chain dysfunctions.   
 
Abbreviations: ANT: adenine nucleotide translocase; AP5A: P1,P5-di(adenosine-5′) 
pentaphosphate; cATR: carboxyatractyloside; DMEM: Dulbecco's Modified Eagle Medium; 
EDTA: Ethylenediaminetetraacetic acid; EGTA: Ethylene glycol-bis(2-aminoethylether)-
N,N,N′,N′-tetraacetic acid; MgGr: magnesium green; SF 6847: Tyrphostin 9, RG-50872, 
Malonaben, 3,5-di-tert-butyl-4-hydroxybenzylidenemalononitrile, 2,6-di-t-butyl-4-(2',2'-
dicyanovinyl)phenol.  
 
INTRODUCTION 
 
Adenine nucleotide translocase (ANT) exchanges ATP for ADP across the inner 
mitochondrial membrane (Klingenberg 1980;Pebay-Peyroula and Brandolin 2004). Because 
ANT transports adenine nucleotides only in the Mg2+-free state (Klingenberg 1980;Kramer 
1980), and Mg2+ has differential affinity for ADP and ATP, we are able to measure ANT 
activity using the membrane-impermeable Mg2+-sensitive fluorescent indicator 'Magnesium 
Green'. In this assay, the rate of change in free extramitochondrial [Mg2+] in the experimental 
medium is measured following addition of ADP to mitochondria. The changes in free 
extramitochondrial [Mg2+] exhibit complete sensitivity to submicromolar amounts of the ANT 
inhibitor, carboxyatractyloside (cATR) (Chinopoulos et al. 2009;Metelkin et al. 2009). The 
rate of change in free [Mg2+] is converted to rate of ATP exported from mitochondria using 
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standard binding equations (Chinopoulos et al. 2009).The ATP-ADP exchange rate mediated 
by the ANT from isolated mitochondria has been validated in (Chinopoulos et al. 2009), 
especially in view of the contribution of the ATP-Mg2+/Pi carrier (Aprille 1993) and a 
homologue of the Mrs2 protein originally described in yeast that mediates an electrophoretic 
uptake of Mg2+ in mitochondria (Kolisek et al. 2003). 
In isolated mitochondria, besides ANT, adenylate kinase and creatine kinase in the 
intermembrane space interconvert adenine nucleotides, but the former is effectively inhibited 
by P1,P5-di(adenosine-5′) pentaphosphate (AP5A) (Lienhard and Secemski 1973), and the 
latter by excluding creatine or its phosphate derivatives in the medium (Chinopoulos et al. 
2009). In permeabilized cells, however, numerous additional enzymes that interconvert 
adenine nucleotides exist. These include phosphorylases, phosphatases and kinases, as well as 
the Na+/K+ ATPase, the plasmalemmal and endoplasmic Ca2+ ATPase, and in contractile cells 
the myosin ATPase. These reactions hamper the use of the binding equations that convert free 
[Mg2+] to ANT-dependent ADP-ATP exchange rate (Chinopoulos et al. 2009). Thus, in 
permeabilized cells, all competing adenine nucleotide interconverting reactions need to be 
inhibited. This is accomplished by the use of BeF3- and vanadium compounds, which 
effectively inhibit ADP and/or ATP utilizing reactions (Cantley, Jr. et al. 1977;Gordon 
1991;Mukherjee et al. 2004;Davies and Hol 2004;Robinson et al. 1986;Werber et al. 
1992;Baukrowitz et al. 1994). In (Kawamata et al. 2010), we used this approach and 
demonstrated ANT-dependent ADP-ATP exchange rate in permeabilized cells, using BeF3- 
and Na3VO4. This method was also applied in determining ANT dysfunction in relation to 
mitochondrial membrane potential in myotubes expressing ANT1 harboring mutations linked 
to autosomal dominant progressive external opthalmoplesia (Kawamata et al. 2011). In these 
studies the conversion of dye emission signal to [Mg2+], and subsequently to ATP, was 
calibrated by obtaining the maximal fluorescence signal with excess [Mg2+] and the minimal 
fluorescence by the addition of the cation chelator, EDTA. However, because Magnesium 
Green is a fluorimetric dye with single excitation and emission, it is subject to the potential 
pitfalls of non-ratiometric dyes related to variations in dye concentration and/or bleaching. In 
practice, this method introduced variability in the measurement of ADP-ATP exchange rate 
and a better calibration was required. Below we describe a step-by-step measurement of 
ANT-dependent adenine nucleotide exchange with a modified calibration method, allowing 
for an error-free conversion of Magnesium Green signal to free extramitochondrial [Mg2+]. 
Furthermore, we present the methods to correlate ADP-ATP exchange rate to mitochondrial 
membrane potential and oxygen consumption. These could become particularly informative 
when studying bioenergetic parameters of cancer cell mitochondria that exhibit decreased or 
complete loss of electron flux associated with impaired respiration and ATP synthesis 
(Kwong et al. 2007).  
 
 
METHODOLOGY 
 
Reagents: Standard laboratory chemicals, P1, P5-Di(adenosine-5′) pentaphosphate (AP5A), 
safranin O, and digitonin from Sigma (St. Louis, MO, USA). Magnesium Green 5K+ salt from 
Life Technologies (Carlsbad, CA, USA). Carboxyatractyloside from Calbiochem (San Diego, 
CA, USA). SF 6847 from Biomol (catalogue number EI-215, BIOMOL GmbH, Hamburg, 
Germany).  
 
Stock reagents and buffers: 
 
25 mM Na3VO4, pH 8.7 (see below how to prepare)   
0.2 M BeSO4 (see below how to prepare)   
0.5 M NaF (see below how to prepare)   
25 mM P1,P5-di(adenosine-5′) pentaphosphate (Ap5A), dissolved in distilled water 
1 mM Carboxyatractyloside (cATR), dissolved in distilled water 
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5 mM Oligomycin (if a mixture of oligomycins A, B, and C are used, i.e. item # O4876 from 
Sigma-Aldrich, assume MW=800), dissolved in ethanol 
0.2 M EDTA 
1 mM Safranin O, dissolved in distilled water 
1.1 mM Magnesium Green 5K+ salt, dissolved in distilled water 
1 M Glutamate, dissolved in distilled water, pH 7 with KOH 
0.5 M Malate, dissolved in distilled water, pH 7 with KOH 
0.2 M ADP, K+ salt (see below how to prepare)  
0.2 M ATP K+ salt (see below how to prepare) 
2.5 mM Digitonin, dissolved in DMSO (see below)   
1 M MgCl2 
1 mM SF 6847, dissolved in ethanol. Do not substitute with FCCP, CCCP, or 2,4-
dinitrophenol (see below). 
 
Buffer A:  
8 mM KCl  
110 mM K-gluconate  
10 mM NaCl 
10 mM Hepes  
10 mM KH2PO4  
0.005 mM EGTA  
10 mM Mannitol  
1 mM MgCl2  
0.5 mg/ml Bovine serum albumin (fatty acid-free) 
pH 7.2  
 
Buffer B:  
Buffer A without MgCl2, but containing 25 μM AP5A, 5 mM NaF, 0.2 mM BeSO4, 30 μM 
Na3VO4, 5 μM EDTA (to chelate nominal amount of Mg2+ in the buffer) and 50 μM digitonin. 
 
Buffer C: 
Same as buffer A, but without MgCl2, and containing 4 μM cATR, 2 μM oligomycin, and 5 
μM EDTA.  
 
Preparation of reagents: 
ADP and ATP are purchased as a K+ salt of the highest purity available and titrated to pH=6.9 
with KOH to make stocks of 0.2 M. Concentration of ADP and ATP stock solutions is 
corrected by measuring absorbance at 260 nm using an extinction coefficient M= 15,400 M-
1*cm-1.  
All other reagents should be dissolved in distilled water, except SF 6847 and oligomycin 
which should be dissolved in ethanol, and digitonin which should be dissolved in DMSO. 
 
Preparation of sodium orthovanadate (Na3VO4) and beryllium trifluoride (BeF3-): A 25 mM 
Na3VO4 solution is prepared in distilled water (>17 megaOhm resistance). The pH of the 
solution is adjusted to 8.7 with HCl, upon which it turns yellow. This solution is boiled until it 
turns colorless and cooled to room temperature. The pH is reassessed, and readjusted to pH 
8.7 with HCl, upon which the solution turns yellow again. This cycle of boiling until colorless 
and readjusting the pH is repeated until the solution remains colorless at pH 8.7.  Finally, the 
solution is brought up to the initial volume with distilled water and stored in aliquots at -80 
°C. This treatment removes all decavanadate ions present in the Na3VO4 solution, which 
induces mitochondrial membrane depolarization and inhibition of oxygen consumption 
(Aureliano and Crans 2009). Orthovanadate inhibits the oxidation of only disrupted 
mammalian mitochondria (Byczkowski et al. 1979). Likewise, fluoroberyllium nucleoside 
diphosphate complexes inhibit only the exposed F1F0-ATPase (Issartel et al. 1991). BeSO4 
and NaF are prepared as aqueous stock solutions of 0.2 M and 0.5 M, respectively, and kept at 
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+4 °C for several years. BeF3- is formed immediately in solution upon mixing of BeSO4 and 
NaF, provided that NaF is in excess in the working solution. 
Vanadate, beryllium and fluoride salts are highly toxic to tissues and to the environment, and 
thus require proper handling and disposal. The combination of orthovanadate and BeF3- will 
inhibit kinases, mutases, phosphatases, and ATPases (Ray et al. 1990;Climent et al. 1981). 
However, some kinases, such as pyruvate kinase, will remain uninhibited (Lord and Reed 
1990). In this respect, upon permeabilization of the cells one has to totally separate pyruvate 
kinase from its substrate, phosphoenol pyruvate, i.e. there must be no glucose present in the 
medium prior to permeabilization, and a few minutes lag time must be allowed prior to ADP-
ATP exchange rate measurements in order for the remaining reactions by kinases to ‘die-out’.     
 
Digitonin stock: Our digitonin powder stocks were purchased as “approximately 50% 
estimated by thin layer chromatography”; therefore we cannot be certain of the exact 
concentration of digitonin present in the measuring chamber. Optimum digitonin amount 
added to the chamber is determined by measuring oxygen consumption in non-permeabilized 
cells using succinate as respiratory substrate, as detailed in (Kawamata et al. 2010) and is the 
one conferring the highest respiratory control ratio. The entire study should be performed 
using the same digitonin stock solution.  
 
Equipment: Oroboros Oxygraph-2k (Oroboros Instruments, Innsbruck, Austria) equipped 
with an LED exhibiting a wavelength maximum of 465 +/- 25 nm (current for light intensity 
adjusted to 2 mA, i.e., level '4') and either an <505 nm shortpass excitation filter (dye-based, 
filter set "Safranin" or an <495 nm shortpass excitation filter (dye-based, filter set "MgG / 
CaG"). Emitted light is detected by a photodiode (range of sensitivity: 350-700 nm), through 
either an >560 nm longpass emission filter (dye-based) for safranin O or an >525 nm 
longpass emission filter for MgGr. A cuvette-based fluorimeter equipped with the capability 
of stirring and thermoregulation would also be suitable (e.g., Hitachi F-7000 
spectrofluorimeter, Hitachi High Technologies, Maidenhead, UK).  
 
Culturing and harvesting of the cells: The amount of cells required varies from one type to 
another. In cell types that contain extremely high amounts of mitochondria, such as in 
differentiated myotubes from mouse C2C12 myoblasts, plating 140,000 myocytes for 
differentiation (by exchanging horse for fetal bovine serum at the time when myocytes are 
over 90% confluent) is sufficient for the assay. For other cells, such as human fibroblasts, 1-2 
million cells are required. Below, we present results obtained from HEK293 cells (~400,000 
cells per assay). Regardless of the cell type: cells are washed once in phosphate-buffered 
saline and harvested with 0.1 ml of 0.25% trypsin-EDTA, inactivated by 0.9 ml calf serum, 
followed by centrifugation at 1,100 g for 2 minutes. Next, cells are washed once in buffer A 
without disturbing the pellet. After the wash, cells are resuspended in 0.2 ml of the buffer B. 
This buffer contains the same base composition as buffer A described above, but includes 
substrates (glutamate and malate) as well as inhibitors. See steps below for specific 
concentrations of substrates and inhibitors to include. The rationale for using this particular 
buffer composition is elaborated in (Chinopoulos et al. 2009). Glutamate and malate as 
mitochondrial substrates were chosen on the basis that they support mitochondrial substrate-
level phosphorylation, and as such, they contribute to greater ATP efflux rates (Chinopoulos 
et al. 2010), (Kiss et al. 2013).  
 
Kd determination of ATP and ADP for Mg2+:   
First, one should measure the apparent Kd values of ADP for Mg2+ and ATP for Mg2+ for the 
pertaining conditions (media, temperature, ionic strength, type and amount of cells, etc), steps 
1-7.  
 
1) Cells resuspended in 2 ml of buffer C are added to a chamber of an Oroboros Oxygraph-
2k. The presence of cATR and oligomycin in the buffer is only required for the Kd 
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determination. Magnesium Green fluorescence is recorded by the O2k-Fluorescence 
LED2-Module at a 1 Hz acquisition rate. Experiments are performed at 37 oC. Digitonin 
(see above regarding remarks about its concentration) and Magnesium Green 5K+ salt 
(MgGr; 1 M) are subsequently added to the chamber.  
 
2) MgGr fluorescence signal is recorded upon stepwise additions of 0.1 mM MgCl2 for a total 
of 10 additions (about 50 sec of recording time per addition). This is shown in figure 1A, 
on the left side of the dashed line.  
 
3) Continuing in same cells in the chamber, add 0.25 mM ADP in subsequent steps for a 
total of 19 steps (about 50 sec of recording time per addition). This is shown in figure 1A, 
on the right side of the dashed line.  
 
4) Likewise, in a new cell preparation, repeat Steps 1- 3, but with 11 additions of 0.2 mM 
ATP instead of ADP, also shown in figure 1A.  
 
5) Convert the MgGr signal of both left and right part of figure 1A to free [Mg2+]. To do 
this, plot the steady-states of MgGr after each addition of MgCl2 (as seen in the left part 
of figure 1A) on the y-axis as a function of [Mg2+] (x-axis) and apply the following fit 
equation (you can use either trace): f=y0+a*(1-exp(-b*x)). This is an exponential rise to 
maximum equation with a 3 parameter function, where y0, a, and b are coefficients. The 
results are shown in figure 1B. 
 
6) Calibrate the right part of figure 1A, using the coefficients y0, a, and b determined from 
step 5, shown in figure 1B, by solving the following exponential function for x: x=(-
1/b)*ln(1-((f-y0)/a)). After calibration of MgGr signals obtained in figure 1A, it should 
look like figure 1C. If calibration was performed correctly, the left parts of both traces 
should be almost identical. 
 
7) Next, from the calibrated right part of figure 1C, the Kd of ADP for Mg2+ and the Kd of 
ATP for Mg2+ is estimated by fitting the following equation with the least squares method 
to the data points: 
[Mg [Mg [Mg [Mg2 0 5 2 2
2 24          FH
I
K] . ] [ ] ] [ ] ]f t d t t d t d tK L K L Kc h , 
where [Mg2+]t is the total [Mg2+] (1 mM), [L]t is the total concentration of added ADP (or 
ATP). The least square fitting method can be performed by a customized Excel tool or 
other freely available software. The fitted curves are shown in figure 1D for both ADP 
and ATP. The Kd determined are Kd _ADP= 0.914 +/- 0.028 mM, and Kd _ATP=0.147 +/- 
0.008 mM. Since Kd values are now known for the pertaining experimental conditions, 
ADP-ATP exchange rates can be calculated from the MgGr recordings.  
 
[Mg2+]free determination from Magnesium Green fluorescence in permeabilized cells and 
conversion to ADP-ATP exchange rate:  
 
1) Add 1.1 M of MgGr in 1.8 ml of buffer B. Record MgGr fluorescence for a few minutes 
and allow the signal to stabilize. In the meantime, harvest cells by trypsinization as 
elaborated above. Cells are washed once with buffer A and then resuspended in 0.2 ml of 
buffer B.  
 
2) Upon addition of cells to the measuring chamber, wait 3 minutes and resume recording. 
After 2 minutes, add a known amount of ADP; we suggest 2 mM ADP. When ADP is 
added, the fluorescence signal will drop, as shown in figure 2A. Subsequently, the 
uncoupler SF 6847 is added to the chamber in 10 nM increments (~100 seconds between 
each interval); this will be used later on to correlate the ATP efflux rates with membrane 
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potential changes, see below. It is important to use SF 6847 and not the more widely used 
FCCP, CCCP, or 2,4-dinitrophenol, because SF 6847 is the only uncoupler that does not 
quench Magnesium Green fluorescence up to a concentration of 1 M (SF 6847 is also 
appropriate to use with Calcium Green, a Ca2+-sensitive dye; this is not unexpected as 
both Calcium Green and Magnesium Green are fluorescein derivatives). 
 
3) Figure 2B shows the free [Mg2+] calibrated from MgGr raw fluorescence. One may notice 
that initial total [Mg2+] was measured to be 1.1486 mM, i.e. not exactly 1 mM, which was 
the actual amount added into the chamber. After the addition of 2 mM ADP, free [Mg2+] 
was measured to attain the value of 0.5553 mM, i.e. not the exact value of 0.3958 mM, 
which is what would be expected. The value of 0.3958 mM was derived from the 
equation below: 
[Mg [Mg [Mg [Mg2 0 5 2 2
2 24          FH
I
K] . ] [ ] ] [ ] ]f t d t t d t d tK L K L Kc h  
where [Mg2+]t is the total [Mg2+] (1 mM), [L]t is the total concentration of added ADP (or 
ATP), and Kd is the fitted value of KADP or KATP, respectively. These errors stem from the 
fact that MgGr is not a ratiometric dye, and thus it is subject to the pitfalls elaborated 
above. It is therefore necessary to adjust the whole trace shown in figure 2B so that the 
value just prior to addition of 2 mM ADP is 1 mM [Mg2+] (the total), and the first value of 
[Mg2+] after the addition of 2 mM ADP is 0.3958 mM. From figure 1B, it is apparent that 
the relation between free [Mg2+] and MgGr fluorescence signal in the 0-0.5 mM range is 
fairly linear, see also (Chinopoulos et al. 2009). Thus, one may apply a series of simple 
arithmetic operations to correct the errors: the difference between the measured total 
[Mg2+] (1.1486 mM) and the measured first value of [Mg2+] after the addition of 2 mM 
ADP (0.5553 mM) is 0.5933 mM, while the difference between the actual total [Mg2+]  (1 
mM) and the expected first value of [Mg2+] after the addition of 2 mM ADP (0.3958 mM) 
is 0.6042 mM; therefore, the measured changes in free [Mg2+] are underestimated by a 
factor of 0.6042/0.5553=1.01837. Thus, the whole trace of figure 2B is multiplied by 
1.01837. This would generate a trace in which the value of [Mg2+] just prior to addition of 
2 mM ADP is 1.169 mM (the estimated total), and the first value of [Mg2+] after the 
addition of 2 mM ADP is 0.5655 mM (not shown). By subtracting the difference of 
1.169-1=0.169 mM from this whole trace, the final trace should look like the one depicted 
in figure 2C. Note that in the trace shown in figure 2C the value just prior to addition of 2 
mM ADP is 1 mM [Mg2+] (the total), and the first value of [Mg2+] after the addition of 2 
mM ADP is 0.3958 mM. The trace depicting the estimated [Mg2+] has therefore been 
corrected, and the conversion to ATP appearing in the medium can now be applied, as 
shown in the next step.   
 
4) We convert the corrected [Mg2+] values to ATP appearing in the medium, using the 
equation below: 
 
[ ]
[ ]
[ ]
[ ] [ ]
[ ] [ ] [ ]
ATP
Mg
Mg
ADP (t = 0) + ATP (t = 0)
Mg Mg Mgt
2+
t
2+
f
t t
ADP
2+
f ATP
2+
f ADP
2+
f
      
F
HG
I
KJ
F
HG
I
KJ1
1 1
K K K
  
The above equation is available for download as an executable file at 
http://www.tinyurl.com/ant-calculator. The rate of ATP appearing in the medium can be 
calculated by making a linear regression for the ATP values as a function of time, as 
shown in figure 2D. 
 
Mitochondrial membrane potential (ΔΨm) determination in in situ mitochondria of 
permeabilized cells:  
ΔΨm is estimated using fluorescence quenching of the cationic dye safranin O due to its 
accumulation inside energized mitochondria (Akerman and Wikstrom 1976), also taking into 
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account the considerations discussed in (Perevoshchikova et al. 2009) and (Figueira et al. 
2012). 
 
1) Cells are treated exactly as described for free [Mg2+] determination, except that MgGr is 
replaced by 5 M safranin O.  
 
2) Fluorescence is recorded in an Oroboros Oxygraph-2k at a 1 Hz acquisition rate, using 
the 495 nm excitation and 585 nm emission wavelengths. Experiments are performed at 
37 oC. After the baseline signal has stabilized, 2 mM ADP is added to the chamber and 
fluorescence is allowed to stabilize. The raw signal of safranin O fluorescence is shown in 
figure 3A. 
 
3) After addition of ADP, m is further depolarized stepwise by addition of 10 nM SF 
6847 until the signal after depolarization becomes stable (~100 sec). Safranin O 
fluorescence is converted to mV (figure 3B) using the Nernst equation and assuming a 
matrix [K+]=120 mM, which was determined by a voltage-fluorescence calibration curve 
of safranin O fluorescence in the presence of 2 nM valinomycin and increasing [K+] (0.2-
120 mM; (Akerman and Wikstrom 1976)). An important note is that cancer cells express 
very variable levels of IF1 (Sanchez-Arago et al. 2013), which inhibits the ATP-
hydrolytic function of the ATPase, thus hindering reversal rates. Therefore, it is not 
recommended to study ATP influx rates in mitochondria from cancer cells, i.e. at very 
depolarized values. The method is suitable for studying cancer mitochondria during ATP 
synthesis. 
 
Mitochondrial respiration:  
Oxygen consumption is simultaneously measured with Safranin O reflecting m or MgGr 
fluorescence reflecting ADP-ATP exchange rates in the same samples polarographically 
using the Oxygraph-2k. Oxygen concentration (black trace of figure 3C) and oxygen flux 
(grey trace of figure 3C) expressed as pmol·s−1·mg−1; negative time derivative of oxygen 
concentration, divided by tissue mass per volume and corrected for instrumental background 
oxygen flux arising from oxygen consumption of the oxygen sensor and back-diffusion into 
the chamber) were recorded using DatLab software (Oroboros Instruments).  
 
From the above measured parameters, one is able to estimate the rate of ATP appearing in the 
medium as a function of m or oxygen consumption rate. 
 
CONCLUSIONS AND COMMENTS 
 
Using this technique we have previously addressed ANT-dependent adenine nucleotide 
exchange in disease conditions (Kawamata et al. 2011). By generating ADP-ATP exchange 
rate/m profile for myotubes expressing ANT1 with pathogenic mutations, we found that 
the mutations caused a reduced ADP-induced depolarization of membrane potential. This 
suggested that mutant ANT1 expressing cells require more m to generate the same amount 
of ATP. In the same cells, ATP synthesis measured by a luciferase-based method did not 
show significant differences between mutant and wild type ANT1 expressing cells. Thus, this 
is a sensitive method to determine ATP production from mitochondria. Furthermore, with the 
presently described methodology, one is provided the capacity to measure ADP-ATP 
exchange rate in a kinetic mode together with oxygen consumption, in addition to recording 
changes in m. This may be particularly informative when studying bioenergetic 
parameters of cancer cell mitochondria, as these are known to exhibit decreased or complete 
loss of electron flux, which leads to impaired respiration and ATP synthesis (Kwong et al. 
2007).  
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FIGURE LEGENDS 
 
Figure 1: Magnesium green fluorescence calibration and estimation of Kd of ATP and 
ADP for Mg2+. A: Reconstructed time-recordings of MgGr raw fluorescence traces in 
permeabilized HEK293 cells as a function of extramitochondrial [Mg2+] (left part of the 
traces), and as a function of extramitochondrial ADP or ATP (right parts of the traces). B: 
MgGr fluorescence changes are dependent on extramitochondrial [Mg2+]. C: Calibrated time-
recordings of extramitochondrial [Mg2+] (left part of the traces), and as a function of 
extramitochondrial ADP and ATP (right parts of the traces) are shown. D: Calibrated 
extramitochondrial Mg2+ plots as a function of ADP or ATP are shown, from which we 
estimated  Kd of ADP and ATP for Mg2+ using the least squares method to fit the data. 
 
Figure 2: Determination of extramitochondrial [Mg2+] and conversion to ATP. A: 
Reconstructed time recording of MgGr raw fluorescence in permeabilized HEK293 cells upon 
addition of 2 mM ADP (where indicated), followed by incremental 10 nM additions of the 
uncoupler SF 6847. B: Calibrated time recording of extramitochondrial [Mg2+] obtained from 
panel 2A. C: Corrected calibrated trace of panel 2B, as described in the text. D: Calculated 
amount of ATP appearing in the medium converted from panel 2C. The rate of ATP 
appearing in the medium is indicated in mol/min/mg protein.  
 
Figure 3: Mitochondrial membrane potential and oxygen consumption determination in 
permeabilized cells. A: Reconstructed time recording of Safranin O raw fluorescence in 
permeabilized HEK293 cells upon addition of 2 mM ADP (where indicated), followed by 
incremental 10 nM additions of the uncoupler SF 6847. B: Calibrated time recording of m 
obtained from panel 3A. C: Reconstructed time recording of oxygen concentration in the 
medium (black trace) and oxygen flux (grey trace) recorded simultaneously with either MgGr 
signal (panel 2A) or Safranin O signal (panel 3A).   
 
 
